Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company based in the U.S., with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
The Pure-Vu® System is a 510(k) U.S. Food and Drug Administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. The Pure-Vu® System has received CE mark approval in Europe.
Location: United States, Florida, Fort Lauderdale
Employees: 11-50
Phone: 908-996-0239
Total raised: $43.5M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Perceptive... | perceptive... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.12.2018 | - | $13.5M | - |
| 28.02.2017 | - | $30M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | David | Hochman | Chairman | linkedin.c... | - | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 21.07.2021 | Motus GI : Secures Expanded $12M Credit Financing to Support... | Motus GI Secures Expanded $12M Credit Financing to Support Growth Strategy FORT LAUDERDALE, FL., Ju... | marketscre... |
| 21.07.2021 | Motus GI Secures Expanded $12M Credit Financing to Support G... | FORT LAUDERDALE, Fla., July 21, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (&q... | marketscre... |